Growth, Innovation and Leadership Index for Healthcare Attractiveness (GIL-H Index), 2018

Growth, Innovation and Leadership Index for Healthcare Attractiveness (GIL-H Index), 2018

A Data-driven Research-based Country Pipeline System to Gauge Country Competitiveness in Healthcare

RELEASE DATE
03-Apr-2018
REGION
Global
Research Code: 9AE5-00-10-00-00
SKU: CI00471-GL-DE_21740

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
CI00471-GL-DE_21740

$1,500.00

$1,125.00 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Despite global political uncertainties and a subdued economic outlook, 2018 is expected to be promising for the global healthcare industry, supported by implementation of major health policies and initiatives. However, the global surge in drug prices will compel pharmaceutical and biotech companies to focus more on innovation as well as on a more favorable regulatory landscape for improved pricing flexibility to help them gauge the demand for healthcare drugs, devices and services.

Despite seeing slow growth, rich counties are re-emerging; BRICS, the economic powerhouse, has started to fall apart, and new emerging and frontier markets are proving to be resilient. With corporates increasingly challenged by the need to invest in technological advancements and th need to find stable sociopolitical environment in countries, a business expansion decision will not be limited to a country’s “size”.

The GIL-H Index or the Growth, Innovation, and Leadership Index for Healthcare Attractiveness essentially helps identify go-to investment destination using a robust data-driven approach, whereby countries are evaluated across multiple indicators under the Growth (G), Innovation (I), Leadership (L) and Healthcare (H) pillars. The growth pillar parameters help companies gauge the economic landscape and living standards of countries. The Innovation pillar captures a country’s innovation ecosystem strength and human resource capabilities. The Leadership pillar highlights a government’s effectiveness in establishing an enabling business environment for investors. The Healthcare pillar reflects the country’s strength in generating demand for the healthcare sector. This index is a generalized model and can be specifically engineered for client growth objectives.

The GIL-100 index evaluates and furnishes composite ranks for 110 countries with a Gross Domestic Product (GDP) at and above $20 billion by giving specific weights to G, I, L, and H indicators. The results have further been analyzed under three altering scenarios by assigning changing weights to each of the pillars. Scenario I puts highest weightage to the H pillar, with the remaining weights distributed between the G, I, and L. Scenario II allocates 95% of the weights between H and G, with weightages of just 5% for I and L. Scenario III assigns highest weights to I followed by L, with G and H. The altering scenarios are also backed by hypothetical case examples that clearly highlight how the GIL Index results can be leveraged with changing client pressure points. A few country profiles from each region are also provided to highlight country drivers and challenges.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Research Overview—GIL-H Index

Research Methodology—GIL-H Index

GIL-H Results—Key Emerging Markets, 2018

Trends and Opportunities in Healthcare, 2017 and Beyond

Trends and Opportunities in Healthcare, 2017 and Beyond (continued)

State of Healthcare 2017

The Need for a Country Ranking Framework

Frost & Sullivan’s Proprietary GIL Framework and Introduction to GIL-H Index

Country Coverage by Region & GDP Bracket

Methodology

Using GIL-H Index—A Simple 3-Step Process

Indicators Coverage in the GIL-H Index, 2018

GIL-H Index Scenario Analysis and Results

Results Per Scenario

Scenario I Hypothetical

Scenario II Hypothetical

Scenario III Hypothetical

South Africa

South Africa (continued)

Chile

Chile (continued)

India

India (continued)

Kazakhstan

Kazakhstan (continued)

Key Conclusions

Legal Disclaimer

Indicators Used in the GIL-H Index 2018

Indicators Used in the GIL-H Index 2018 (continued)

Indicators Used in the GIL-H Index 2018 (continued)

Country List, GIL-H Index, 2018

Country List, GIL-H Index, 2018 (continued)

Global Results

Regional Results—Africa, Americas, Asia-Pacific

Regional Results—Central Asia, Eastern Europe, Middle East, Western Europe

Global Results by GDP Bracket

Global Results by GDP Bracket (continued)

Global Results

Regional Results—Africa, Americas, Asia-Pacific

Regional Results—Central Asia, Eastern Europe, Middle East, Western Europe

Global Results by GDP Bracket

Global Results by GDP Bracket (continued)

Global Results

Regional Results—Africa, Americas, Asia-Pacific

Regional Results—Central Asia, Eastern Europe, Middle East, Western Europe

Global Results by GDP Bracket

Global Results by GDP Bracket (continued)

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
Despite global political uncertainties and a subdued economic outlook, 2018 is expected to be promising for the global healthcare industry, supported by implementation of major health policies and initiatives. However, the global surge in drug prices will compel pharmaceutical and biotech companies to focus more on innovation as well as on a more favorable regulatory landscape for improved pricing flexibility to help them gauge the demand for healthcare drugs, devices and services. Despite seeing slow growth, rich counties are re-emerging; BRICS, the economic powerhouse, has started to fall apart, and new emerging and frontier markets are proving to be resilient. With corporates increasingly challenged by the need to invest in technological advancements and th need to find stable sociopolitical environment in countries, a business expansion decision will not be limited to a country’s “size”. The GIL-H Index or the Growth, Innovation, and Leadership Index for Healthcare Attractiveness essentially helps identify go-to investment destination using a robust data-driven approach, whereby countries are evaluated across multiple indicators under the Growth (G), Innovation (I), Leadership (L) and Healthcare (H) pillars. The growth pillar parameters help companies gauge the economic landscape and living standards of countries. The Innovation pillar captures a country’s innovation ecosystem strength and human resource capabilities. The Leadership pillar highlights a government’s effectiveness in establishing an enabling business environment for investors. The Healthcare pillar reflects the country’s strength in generating demand for the healthcare sector. This index is a generalized model and can be specifically engineered for client growth objectives. The GIL-100 index evaluates and furnishes composite ranks for 110 countries with a Gross Domestic Product (GDP) at and above $20 billion by giving specific weights to G, I, L, and H indicators. The results have further be
More Information
No Index No
Podcast No
Author Rituparna Majumder
Industries Cross Industries
WIP Number 9AE5-00-10-00-00
Is Prebook No
GPS Codes 9A6B,9A7B-EM